These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 668976)

  • 1. Hyperlactatemia in diabetics with retinopathy during combined sulphonylurea and phenformin therapy.
    Nattrass M; Arthur MJ; Smythe P; McGill JI; Todd PG; Alberti KG
    Diabete Metab; 1978 Mar; 4(1):1-4. PubMed ID: 668976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic effects of combined sulphonylurea and metformin therapy in maturity-onset diabetice.
    Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
    Horm Metab Res; 1979 May; 11(5):332-7. PubMed ID: 573232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic abnormalities during combined sulphonylurea and phenformin therapy in maturity-onset diabetics.
    Nattrass M; Todd PG; Turnell D; Alberti KG
    Diabetologia; 1978 Jun; 14(6):389-95. PubMed ID: 669103
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lactic acidosis associated with fenformin therapy].
    Ghirlanda G; Greco AV; Altomonte L; Manna R; Pala MA; Rebuzzi AG
    Minerva Med; 1981 Apr; 72(14):893-5. PubMed ID: 7219798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Semi-automatic determination of blood lactate during hypoglycemic treatment with biguanides].
    Gelo Signorino R; Castellazzi R; Gamba S; Grassi G; Zanno C; Bruni B
    Ann Osp Maria Vittoria Torino; 1979; 22(1-6):18-37. PubMed ID: 122229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood lactate and pyruvate levels in diabetic patients treated with biguanides with and without sulphonylureas.
    Waters AK; Morgan DB; Wales JK
    Diabetologia; 1978 Feb; 14(2):95-8. PubMed ID: 631461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum concentration of lactate in diabetic patients treated with biguanides in relationship to renal function (author's transl)].
    Sailer D; Ganawal S; Berg G
    Med Klin; 1979 Mar; 74(9):318-24. PubMed ID: 423858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactic acidosis in phenformin-treated diabetics. A clinical and laboratory study.
    Bengtsson K; Karlberg B; Lindgren S
    Acta Med Scand; 1972 Mar; 191(3):203-8. PubMed ID: 4624476
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood lactate and pyruvate levels in diabetic patient treated with sulphonylureas with and without biguanides.
    Sitprija S; Vajanamarhutue C; Bunnag S
    J Med Assoc Thai; 1982 Feb; 65(2):63-71. PubMed ID: 7077214
    [No Abstract]   [Full Text] [Related]  

  • 10. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
    Irsigler K; Kritz H; Regal H; Foltin E
    Wien Klin Wochenschr; 1978 May; 90(10):332-7. PubMed ID: 654296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenformin and lactic acidosis.
    Conlay LA; Loewenstein JE
    JAMA; 1976 Apr; 235(15):1575-8. PubMed ID: 946271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibrinogen in diabetes mellitus.
    De Silva SR; Shawe JE; Patel H; Cudworth AG
    Diabete Metab; 1979 Sep; 5(3):201-6. PubMed ID: 499635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactic acidosis with phenformin therapy.
    Cleaver T; Carretta R
    Calif Med; 1972 Jul; 117(1):14-9. PubMed ID: 4625114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
    Bruneder H; Klein HJ
    Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the treatment of diabetes mellitus.
    Clarke BF; Duncan LJ
    Practitioner; 1971 Oct; 207(240):498-509. PubMed ID: 5003263
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
    Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
    Lunetta M; Presti C; Mughini MT; Mughini L
    Clin Ter; 1980 Jun; 93(6):657-72. PubMed ID: 6775864
    [No Abstract]   [Full Text] [Related]  

  • 18. Biguanide related lactic acidosis: incidence and risk factors.
    Aguilar C; Reza A; García JE; Rull JA
    Arch Med Res; 1992; 23(1):19-24. PubMed ID: 1308787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alteration of blood lactic acid levels in biguanide therapy in diabetics].
    Yang DP; Liang JZ; Luo ZT
    Sichuan Yi Xue Yuan Xue Bao; 1985 Jun; 16(2):162-5. PubMed ID: 3939266
    [No Abstract]   [Full Text] [Related]  

  • 20. Glucose-insulin treatment of lactic acidosis in phenformin-treated diabetics.
    Kristensen O; Andersen HH; Jensen JB
    Acta Med Scand; 1975 Jun; 197(6):463-5. PubMed ID: 808104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.